Publication date: Available online 2 November 2026 Source: Canadian Journal of Ophthalmology Author(s): Michael Balas, Andrew Mihalache, Aaditeya Jhaveri, Shayaan Kaleem, Marko M. Popovic, Peter J. Kertes, Rajeev H. Muni
Congestive heart failure and other cardiac adverse events after intravitreal anti-VEGF therapy: a systematic review and meta-analysis. // Canadian Journal of Ophthalmology. – URL: https://www.sciencedirect.com/science/article/pii/S0008418226003510?dgcid=rss_sd_all
Congestive heart failure and other cardiac adverse events after intravitreal anti-VEGF therapy: a systematic review and meta-analysis. Canadian Journal of Ophthalmology. https://www.sciencedirect.com/science/article/pii/S0008418226003510?dgcid=rss_sd_all
“Congestive heart failure and other cardiac adverse events after intravitreal anti-VEGF therapy: a systematic review and meta-analysis.” Canadian Journal of Ophthalmology.
@article{article93427,
title = {Congestive heart failure and other cardiac adverse events after intravitreal anti-VEGF therapy: a systematic review and meta-analysis},
journal = {Canadian Journal of Ophthalmology},
url = {https://www.sciencedirect.com/science/article/pii/S0008418226003510?dgcid=rss_sd_all}
}
Abstract Purpose To compare the efficacy of intravitreal dexamethasone (DEX) implant‐based regimen versus ranibizumab‐based regimen for managing retinal exudation and complications in stage 3 Coats' disease. Methods Thirty‐seven eyes...
Abstract Foundation models are rapidly emerging as a major development in ophthalmic artificial intelligence, largely because they can achieve strong downstream performance with fewer labelled images than conventional supervised models,...
Abstract Purpose To evaluate intraretinal fluid (IRF) volume dynamics after switching from aflibercept 2 mg to faricimab in eyes with diabetic macular oedema (DME), stratified by prior response to aflibercept. Methods This retrospective...